Log in to your Inderes Free account to see all free content on this page.

Getinge

174.05

SEK

+0.37 %

GETI B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

7 following

+0.37%

+1.72%

-22.68%

-2.27%

-22.4%

-22.58%

-53.5%

+1.78%

+2,098.07%

Getinge is a global medical technology company that specializes in providing equipment and IT systems to the healthcare and life science industry. The company offers, among other things, solutions for operating theatres, intensive care units, sterilization centers and drug development. The company was founded in 1904 and has its headquarters in Gothenburg.

Market cap

47.41B SEK

Turnover

404.56M SEK

Revenue

EBIT %

P/E

Dividend yield-%

Financial calendar

28.1.

2025

Annual report '24

22.4.

2025

General meeting '24

ShowingAll content types

Regulatory press release11/28/2024, 12:00 PM

Changes of the Nomination Committee of Getinge

Regulatory press release11/7/2024, 1:00 PM

Alexandra Holland appointed as EVP Communications at Getinge

Getinge AB, Audiocast with teleconference, Q3'24

Webcast10/18/2024, 8:00 AM

Getinge AB, Audiocast with teleconference, Q3'24

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release10/18/2024, 6:00 AM

Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

Press release10/15/2024, 1:30 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q3 2024

Press release10/4/2024, 6:00 AM

Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call

Press release9/25/2024, 2:07 PM

Getinge's CE certificate for ECLS consumables reinstated

Press release9/11/2024, 12:57 PM

Getinge completes the acquisition of Paragonix Technologies

Regulatory press release9/1/2024, 6:04 PM

Getinge makes a provision of MBRL 240 related to Brazilian investigation

Regulatory press release8/22/2024, 8:23 PM

Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Getinge AB, Audiocast with teleconference, Q2'24

Webcast7/18/2024, 8:00 AM

Getinge AB, Audiocast with teleconference, Q2'24

Regulatory press release7/18/2024, 6:00 AM

Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers

Press release7/15/2024, 12:30 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q2 2024

Press release7/1/2024, 6:00 AM

Getinge invites fund managers, analysts, and media to Q2 Report 2024 conference call

Getinge, Audiocast with teleconference, 2024

Webcast5/15/2024, 8:00 AM

Getinge, Audiocast with teleconference, 2024

Regulatory press release5/14/2024, 6:15 PM

Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average

Press release5/8/2024, 8:00 AM

Getinge invites fund managers, analysts and media to a Capital Market Update conference call

Regulatory press release4/22/2024, 3:00 PM

Resolutions at Getinge's Annual General Meeting 22 April 2024

Getinge AB, Audiocast with teleconference, Q1'24

Webcast4/22/2024, 11:00 AM

Getinge AB, Audiocast with teleconference, Q1'24

Regulatory press release4/22/2024, 10:00 AM

Getinge Interim Report January-March 2024: Higher sales, strong cash flow and new products creating more customer value

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.